🟡 60/100

Review before taking

  • Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)

The safety score is low because the 100mg dose of niacin is nearly three times the recommended maximum daily limit of 35mg.

Label Data

1 Tablet(s) Serving Size
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

100 mg (500% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 2.9× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 100mg UL 35mg

Other Ingredients

Dicalcium Phosphate Nicotinic Acid Microcrystalline Cellulose Stearic Acid Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Sugar Free

Product Information

📋 Directions for Use

Directions: Take one tablet daily as a dietary supplement.

⚠️ Warnings & Precautions

CAUTION: FOLLOW LABEL DIRECTIONS: Do not exceed 500 mg of Niacin unless under the immediate care of a physician. If you have diabetes, seek the advice of a physician before using this product.

SAFETY SEALED. DO NOT USE IF PRINTED SEAL UNDER CAP IS CUT, TORN, OR MISSING.

Keep out of the reach of children.

NOTE: In some persons, symptoms of flushing or warm feeling may occur immediately after dosage which usually disappear in a short period of time.

🧪 Formulation Notes

NO ARTIFICIAL COLORS OR FLAVORS NO YEAST - NO STARCH - NO SALT NO CHEMICAL SOLVENTS - NO LACTOSE NO WHEAT - NO TRANS FAT - NO SUGAR NO PRESERVATIVES - NO GLUTEN

Potassium Gluconate Tablets USP

Additional Information

SATISFACTION GUARANTEED OR YOUR MONEY BACK.

exchange select X(TM)

Vital in the Release of Energy

USP

Made to U.S. Pharmacopeia (USP) quality, purity, and potency standards. Laboratory tested to dissolve within 60 minutes.

Store at 15(0) - 30(0) C (59(0) - 86(0) F).

FRESHNESS AND POTENCY GUARANTEED THROUGH:

134524-01 BB821 USA641685

Product Details

UPC / SKU 6 14299 51274 0
DSLD Entry Date 2013-08-23
Product Type Vitamin
Form Tablet or Pill
DSLD ID 24723
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →